Brovana and Perforomist will be the first long-acting beta-2 agonists that come in solutions for NEBULIZER use

June 2007

Brovana and Perforomist will be the first long-acting beta-2 agonists that come in solutions for NEBULIZER use.

Both are approved for treating COPD.

Brovana (arformoterol) is an isomer of formoterol...the long-acting beta-2 agonist in Foradil and Symbicort inhalers.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote